首页 > 最新文献

Northern clinics of Istanbul最新文献

英文 中文
Male breast cancer in a single-center experience: Diagnosis, clinicopathological features, and treatment strategies. 单中心经验中的男性乳腺癌:诊断、临床病理特征和治疗策略。
Pub Date : 2024-10-02 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.32815
Deniz Isik, Oguzcan Kinikoglu, Ezgi Turkoglu, Heves Surmeli, Neslihan Buyukmurat

Objective: Although breast cancer is the most common cancer type in women worldwide, it is a rare tumor in men, accounting for less than 1% of all male cancers. Therefore, the characteristics of the tumor, the management of the disease, and our overall survival data are quite limited.

Methods: We retrospectively analyzed the data of 51 male patients diagnosed and treated for breast cancer, whose follow-up processes continue, at our hospital. We examined in detail the patients' age, comorbid diseases, history of concomitant malignancies, family history, stage of the disease, tumor size, lymph node status, estrogen receptor (ER)/progesterone receptor (PR) along with Human Epidermal Growth Factor Receptor-2 (HER-2) status. Additionally, we analyzed the type of surgery, history of radiotherapy, and chemotherapy and hormonal treatments in the adjuvant and metastatic periods.

Results: In our study, where we determined a median survival time of 122 months (29-214), we found that the stage at diagnosis, Eastern Cooperative Oncology Group (ECOG) performance status, and discontinuation of adjuvant endocrine therapy significantly affected survival. While the median survival was not reached in stage 1 patients at diagnosis, the median survival times for stage 2, 3, and 4 patients were 118, 83, and 39 months, respectively. The differences between the groups were statistically significant (p=0.005). Similarly, the median survival was not reached for patients with an ECOG performance status of 0, but it was 84 months for those with a status of 1 and 98 months for those with a status of 2. The differences among these three groups were also statistically significant (p=0.001). The median survival was not reached for patients who completed adjuvant endocrine therapy, whereas it was 83 months for those who discontinued the therapy, with the difference being statistically significant (p=0.021). Besides these data, the presence of perineural invasion was found to be a factor close to statistical significance in terms of survival (p=0.066). Histological subgroups, grade, lymphovascular invasion, adjuvant chemotherapy, and Ki-67 were not significant parameters for survival.

Conclusion: Despite the differences in the stage at diagnosis, response to treatments, lower awareness of the disease, older age at diagnosis, and consequently, the increase in accompanying comorbid diseases, male breast cancer is managed according to studies and guideline recommendations for female breast cancer due to the lack of sufficient randomized studies. By presenting our clinical experience, we have emphasized the necessity for further studies in this field.

目的:尽管乳腺癌是全球女性最常见的癌症类型,但它在男性中却是一种罕见的肿瘤,仅占男性癌症总数的不到 1%。因此,肿瘤的特征、疾病的治疗以及我们的总体生存数据都相当有限:方法:我们回顾性分析了在本院接受诊断和治疗的 51 名男性乳腺癌患者的数据,这些患者的随访过程仍在继续。我们详细研究了患者的年龄、合并疾病、并发恶性肿瘤史、家族史、疾病分期、肿瘤大小、淋巴结状态、雌激素受体(ER)/孕激素受体(PR)以及人类表皮生长因子受体-2(HER-2)状态。此外,我们还分析了手术类型、放疗史以及辅助治疗和转移治疗期间的化疗和激素治疗:在我们的研究中,我们确定的中位生存期为 122 个月(29-214),我们发现,诊断时的分期、东部合作肿瘤学组(ECOG)的表现状态以及辅助内分泌治疗的中断对生存期有显著影响。虽然 1 期患者在确诊时未达到中位生存期,但 2、3 和 4 期患者的中位生存期分别为 118、83 和 39 个月。组间差异具有统计学意义(P=0.005)。同样,ECOG 表 现为 0 的患者的中位生存期也没有达到,但 ECOG 表 现为 1 的患者的中位生存期为 84 个月,ECOG 表 现为 2 的患者的中位生存期为 98 个月。完成辅助内分泌治疗的患者未达到中位生存期,而停止治疗的患者的中位生存期为 83 个月,差异有统计学意义(P=0.021)。除这些数据外,研究还发现,存在神经周围侵犯也是影响生存期的一个因素,且接近统计学意义(P=0.066)。组织学亚组、分级、淋巴管侵犯、辅助化疗和Ki-67都不是影响生存率的重要参数:结论:尽管男性乳腺癌在诊断分期、对治疗的反应、对疾病的认识程度、诊断年龄等方面存在差异,而且伴随的合并症也随之增加,但由于缺乏足够的随机研究,男性乳腺癌的治疗仍遵循女性乳腺癌的研究和指南建议。通过介绍我们的临床经验,我们强调了在这一领域开展进一步研究的必要性。
{"title":"Male breast cancer in a single-center experience: Diagnosis, clinicopathological features, and treatment strategies.","authors":"Deniz Isik, Oguzcan Kinikoglu, Ezgi Turkoglu, Heves Surmeli, Neslihan Buyukmurat","doi":"10.14744/nci.2024.32815","DOIUrl":"10.14744/nci.2024.32815","url":null,"abstract":"<p><strong>Objective: </strong>Although breast cancer is the most common cancer type in women worldwide, it is a rare tumor in men, accounting for less than 1% of all male cancers. Therefore, the characteristics of the tumor, the management of the disease, and our overall survival data are quite limited.</p><p><strong>Methods: </strong>We retrospectively analyzed the data of 51 male patients diagnosed and treated for breast cancer, whose follow-up processes continue, at our hospital. We examined in detail the patients' age, comorbid diseases, history of concomitant malignancies, family history, stage of the disease, tumor size, lymph node status, estrogen receptor (ER)/progesterone receptor (PR) along with Human Epidermal Growth Factor Receptor-2 (HER-2) status. Additionally, we analyzed the type of surgery, history of radiotherapy, and chemotherapy and hormonal treatments in the adjuvant and metastatic periods.</p><p><strong>Results: </strong>In our study, where we determined a median survival time of 122 months (29-214), we found that the stage at diagnosis, Eastern Cooperative Oncology Group (ECOG) performance status, and discontinuation of adjuvant endocrine therapy significantly affected survival. While the median survival was not reached in stage 1 patients at diagnosis, the median survival times for stage 2, 3, and 4 patients were 118, 83, and 39 months, respectively. The differences between the groups were statistically significant (p=0.005). Similarly, the median survival was not reached for patients with an ECOG performance status of 0, but it was 84 months for those with a status of 1 and 98 months for those with a status of 2. The differences among these three groups were also statistically significant (p=0.001). The median survival was not reached for patients who completed adjuvant endocrine therapy, whereas it was 83 months for those who discontinued the therapy, with the difference being statistically significant (p=0.021). Besides these data, the presence of perineural invasion was found to be a factor close to statistical significance in terms of survival (p=0.066). Histological subgroups, grade, lymphovascular invasion, adjuvant chemotherapy, and Ki-67 were not significant parameters for survival.</p><p><strong>Conclusion: </strong>Despite the differences in the stage at diagnosis, response to treatments, lower awareness of the disease, older age at diagnosis, and consequently, the increase in accompanying comorbid diseases, male breast cancer is managed according to studies and guideline recommendations for female breast cancer due to the lack of sufficient randomized studies. By presenting our clinical experience, we have emphasized the necessity for further studies in this field.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"434-439"},"PeriodicalIF":0.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of school achievements in adolescents with primary hypertension. 评估原发性高血压青少年的学习成绩。
Pub Date : 2024-10-01 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.34438
Emre Leventoglu, Akif Kavgaci, Furkan Cagri Kavas, Fatma Canbeyli Hayvaci, Bahar Buyukkaragoz

Objective: Primary hypertension (HT) is a global public health problem with increasing prevalence in recent years. HT may have caused decreased neurocognitive functions and learning difficulties. In this study, clinical characteristics of adolescents with primary HT were examined and the relationship between semester grade point average (GPA) and HT was evaluated.

Methods: This is an observational, cross-sectional, descriptive study conducted on adolescents with primary HT attending high school. Patient records (number of hospital visits, HT-related complaints, blood pressure measurements, and laboratory tests) were evaluated retrospectively. End-of-semester report card grades of Mathematics, Turkish Language and Literature and English courses were noted, and compared with the clinical characteristics of the patients.

Results: The study included 83 patients with a mean age of 15.6±1.2 years. Patients with higher body mass index had lower grades in Mathematics (p=0.007) and Turkish Language and Literature (p=0.004). Patients with HT-related symptoms such as headache, epistaxis and palpitations had lower GPAs for all courses. Also, patients with hyperuricemia or proteinuria had lower semester GPAs compared to patients with normal serum uric acid levels or without proteinuria (p<0.05). GPAs for Mathematics (p=0.000) and Turkish Language and Literature (p=0.006) decrease as the number of hospital visits increases.

Conclusion: HT may cause not only cardiovascular complications but also decreased neurocognitive functions through various mechanisms and may have a negative impact on academic skills. Therefore, HT should be followed up with a multidisciplinary approach and intensive efforts should be made to approach the goal of normotension.

目的:原发性高血压(HT)是一个全球性的公共卫生问题,近年来发病率不断上升。高血压可能导致神经认知功能下降和学习困难。本研究考察了原发性高血压青少年的临床特征,并评估了学期平均学分绩点(GPA)与高血压之间的关系:这是一项观察性、横断面、描述性研究,研究对象是患有原发性高血压的高中青少年。对患者记录(医院就诊次数、高血压相关主诉、血压测量和实验室检查)进行了回顾性评估。记录了数学、土耳其语言文学和英语课程的学期末成绩单成绩,并与患者的临床特征进行了比较:研究共纳入 83 名患者,平均年龄为(15.6±1.2)岁。体重指数较高的患者数学(p=0.007)和土耳其语言文学(p=0.004)成绩较低。有高血压相关症状(如头痛、鼻衄和心悸)的患者所有课程的平均学分绩点都较低。此外,与血清尿酸水平正常或无蛋白尿的患者相比,高尿酸血症或蛋白尿患者的学期 GPA 较低(p 结论:高尿酸血症不仅可能导致心血管并发症,还可能通过各种机制导致神经认知功能下降,并对学习能力产生负面影响。因此,应采用多学科方法对高血压进行随访,并努力实现血压正常的目标。
{"title":"Evaluation of school achievements in adolescents with primary hypertension.","authors":"Emre Leventoglu, Akif Kavgaci, Furkan Cagri Kavas, Fatma Canbeyli Hayvaci, Bahar Buyukkaragoz","doi":"10.14744/nci.2024.34438","DOIUrl":"10.14744/nci.2024.34438","url":null,"abstract":"<p><strong>Objective: </strong>Primary hypertension (HT) is a global public health problem with increasing prevalence in recent years. HT may have caused decreased neurocognitive functions and learning difficulties. In this study, clinical characteristics of adolescents with primary HT were examined and the relationship between semester grade point average (GPA) and HT was evaluated.</p><p><strong>Methods: </strong>This is an observational, cross-sectional, descriptive study conducted on adolescents with primary HT attending high school. Patient records (number of hospital visits, HT-related complaints, blood pressure measurements, and laboratory tests) were evaluated retrospectively. End-of-semester report card grades of Mathematics, Turkish Language and Literature and English courses were noted, and compared with the clinical characteristics of the patients.</p><p><strong>Results: </strong>The study included 83 patients with a mean age of 15.6±1.2 years. Patients with higher body mass index had lower grades in Mathematics (p=0.007) and Turkish Language and Literature (p=0.004). Patients with HT-related symptoms such as headache, epistaxis and palpitations had lower GPAs for all courses. Also, patients with hyperuricemia or proteinuria had lower semester GPAs compared to patients with normal serum uric acid levels or without proteinuria (p<0.05). GPAs for Mathematics (p=0.000) and Turkish Language and Literature (p=0.006) decrease as the number of hospital visits increases.</p><p><strong>Conclusion: </strong>HT may cause not only cardiovascular complications but also decreased neurocognitive functions through various mechanisms and may have a negative impact on academic skills. Therefore, HT should be followed up with a multidisciplinary approach and intensive efforts should be made to approach the goal of normotension.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"476-484"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evaluation of potential drug-drug interactions with antibiotics in hospitalized patients. 评估住院病人使用抗生素可能产生的药物间相互作用。
Pub Date : 2024-10-01 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.82473
Nurten Nur Aydin, Murat Aydin

Objective: Drug-drug interactions (DDIs) occur when one drug alters the effect of another drug. The aim of this study was to evaluate potential drug-drug interactions (pDDIs) associated with the use of systemic antibiotics in hospitalized patients.

Methods: The study included patients over the age of 18 who were hospitalized in our hospital on 12.07.2022 and were using at least two systemic drugs concurrently, with at least one being a systemic antibiotic. The study was conducted using the point prevalence method. The patients' medication was evaluated for pDDIs using the UpToDate®/Lexicomp® database system. According to this screening tool, pDDIs were classified into 4 groups according to their severity: B, C, D, and X, ranging from mild to severe.

Results: Out of the 296 patients included in the study, at least one pDDI was detected in 190 patients (64.2%). One hundred seventy-seven patients (59.8%) had at least one pDDI with non-antibiotic drugs. Fifty-seven patients (19.3%) had at least one pDDI with antibiotics. One hundred and six patients (35.8%) had no drug interactions. Patients with pDDIs related to antibiotics had significantly higher age, number of comorbidities, total number of medications and number of antibiotics (p=0.010, p=0.004, p<0.001, p<0.001, respectively) compared to patients without pDDIs related to antibiotics (n=239). For antibiotics, potential pDDIs were observed 25, 75, 6, and 6 times in groups B, C, D, and X, respectively. Out of the total of 398 antibiotics, penicillins (24.9%, n=99) and cephalosporins (24.4%, n=97) were the most frequently used. Respectively, eight and two pDDIs were detected with these drugs. While quinolones were used 47 times (11.8%), 74 pDDIs (59.7%) were identified with quinolones. Out of the 47 patients who used quinolones, 37 had pDDIs with antibiotics. The most frequent pDDI with antibiotics was associated with the use of quinolone systemic corticosteroids (15 patients). The second most prevalent interaction involves quinolone-angiotensin converting enzyme inhibitors or angiotensin 2 receptor blockers (13 patients).

Conclusion: Antibiotics should be checked for pDDIs before being prescribed. While beta-lactam antibiotics are generally considered safer in terms of pDDIs, greater caution should be exercised, particularly when prescribing quinolones.

目的:当一种药物改变另一种药物的作用时,就会发生药物间相互作用(DDI)。本研究旨在评估住院患者在使用全身性抗生素时可能发生的药物相互作用(pDDIs):研究对象包括 2022 年 7 月 12 日在我院住院的 18 岁以上患者,他们至少同时使用两种全身性药物,其中至少一种是全身性抗生素。研究采用点流行法进行。使用 UpToDate®/Lexicomp® 数据库系统对患者的药物进行了 pDDIs 评估。根据这一筛查工具,pDDIs 按其严重程度被分为 4 组:结果:在纳入研究的 296 名患者中,有 190 名患者(64.2%)至少发现了一种 pDDI。177 名患者(59.8%)在使用非抗生素药物时至少出现过一次 pDDI。57 名患者(19.3%)至少有一次使用抗生素进行 pDDI。116 名患者(35.8%)没有发生药物相互作用。与抗生素相关的 pDDIs 患者的年龄、合并症数量、用药总数和抗生素数量均明显高于其他患者(P=0.010、P=0.004、P=0.004):在开具抗生素处方之前,应检查是否存在 pDDIs。虽然就 pDDIs 而言,β-内酰胺类抗生素通常被认为是更安全的,但应更加谨慎,尤其是在处方喹诺酮类抗生素时。
{"title":"The evaluation of potential drug-drug interactions with antibiotics in hospitalized patients.","authors":"Nurten Nur Aydin, Murat Aydin","doi":"10.14744/nci.2023.82473","DOIUrl":"10.14744/nci.2023.82473","url":null,"abstract":"<p><strong>Objective: </strong>Drug-drug interactions (DDIs) occur when one drug alters the effect of another drug. The aim of this study was to evaluate potential drug-drug interactions (pDDIs) associated with the use of systemic antibiotics in hospitalized patients.</p><p><strong>Methods: </strong>The study included patients over the age of 18 who were hospitalized in our hospital on 12.07.2022 and were using at least two systemic drugs concurrently, with at least one being a systemic antibiotic. The study was conducted using the point prevalence method. The patients' medication was evaluated for pDDIs using the UpToDate<sup>®</sup>/Lexicomp<sup>®</sup> database system. According to this screening tool, pDDIs were classified into 4 groups according to their severity: B, C, D, and X, ranging from mild to severe.</p><p><strong>Results: </strong>Out of the 296 patients included in the study, at least one pDDI was detected in 190 patients (64.2%). One hundred seventy-seven patients (59.8%) had at least one pDDI with non-antibiotic drugs. Fifty-seven patients (19.3%) had at least one pDDI with antibiotics. One hundred and six patients (35.8%) had no drug interactions. Patients with pDDIs related to antibiotics had significantly higher age, number of comorbidities, total number of medications and number of antibiotics (p=0.010, p=0.004, p<0.001, p<0.001, respectively) compared to patients without pDDIs related to antibiotics (n=239). For antibiotics, potential pDDIs were observed 25, 75, 6, and 6 times in groups B, C, D, and X, respectively. Out of the total of 398 antibiotics, penicillins (24.9%, n=99) and cephalosporins (24.4%, n=97) were the most frequently used. Respectively, eight and two pDDIs were detected with these drugs. While quinolones were used 47 times (11.8%), 74 pDDIs (59.7%) were identified with quinolones. Out of the 47 patients who used quinolones, 37 had pDDIs with antibiotics. The most frequent pDDI with antibiotics was associated with the use of quinolone systemic corticosteroids (15 patients). The second most prevalent interaction involves quinolone-angiotensin converting enzyme inhibitors or angiotensin 2 receptor blockers (13 patients).</p><p><strong>Conclusion: </strong>Antibiotics should be checked for pDDIs before being prescribed. While beta-lactam antibiotics are generally considered safer in terms of pDDIs, greater caution should be exercised, particularly when prescribing quinolones.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"398-405"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rheumatic diseases detected in patients presenting with uveitis. 在葡萄膜炎患者中发现风湿病。
Pub Date : 2024-10-01 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.14564
Esin Ozturk, Tuba Yuce Inel, Mahmut Kaya, Gercek Sen

Objective: Uveitis may occur in the course of systemic inflammatory rheumatic diseases (IRD), or it may be the first clinical manifestation of these diseases. The aim of this study was to determine the incidence of IRD in patients whose initial clinical manifestation was non-infectious uveitis.

Methods: The study included adult patients diagnosed as having noninfectious uveitis in the department of ophthalmology and referred to rheumatology for further investigation of potential rheumatic diseases as underlying etiology of uveitis. The patients' demographic and clinical features, laboratory, and imaging findings were examined.

Results: One hundred six patients who were diagnosed as having uveitis (42.4% anterior, 2.8% intermediate, 19.8% posterior, and 34.9% panuveitis) were included. Just over half (52.8%) of the patients were male and the mean age was 40.1±14.8 years. The mean age at the uveitis attack was 38.7±15 years. One-third (33%) of the patients were diagnosed as having rheumatologic disease (spondyloarthritis (SpA) n=10, Behcet disease (BD) n=17, vasculitides n=2, sarcoidosis n=2, undifferentiated connective tissue diseases n=3, rheumatoid arthritis n=1). SpA was diagnosed in 20% of patients presenting with anterior uveitis. BD was detected in 27% of patients referred with panuveitis and in 33.3% of patients whose first clinical finding was posterior segment involvement. Bilateral uveitis was detected in two-thirds of patients with posterior uveitis and tended to recur more frequently (p=0.014).

Conclusion: Rheumatic diseases have been identified in approximately one-third of patients presenting with different types of uveitis. Investigations addressing systemic rheumatic diseases are of paramount importance in patients with uveitis because they may change diagnosis and treatment processes.

目的:葡萄膜炎可能发生在全身性炎症性风湿病(IRD)的病程中,也可能是这些疾病的首发临床表现。本研究旨在确定最初临床表现为非感染性葡萄膜炎的患者中 IRD 的发病率:研究对象包括在眼科确诊为非感染性葡萄膜炎并转诊至风湿免疫科进一步检查葡萄膜炎潜在病因风湿病的成年患者。对患者的人口统计学特征、临床特征、实验室和影像学检查结果进行了研究:共纳入了 16 名被诊断为葡萄膜炎的患者(42.4% 前葡萄膜炎、2.8% 中葡萄膜炎、19.8% 后葡萄膜炎和 34.9% 泛葡萄膜炎)。一半以上(52.8%)的患者为男性,平均年龄为 40.1±14.8 岁。葡萄膜炎发作时的平均年龄为 38.7±15 岁。三分之一(33%)的患者被诊断为患有风湿病(脊柱关节炎(SpA)10 人,白塞病(BD)17 人,血管炎 2 人,类肉瘤病 2 人,未分化结缔组织病 3 人,类风湿性关节炎 1 人)。20%的前葡萄膜炎患者被诊断为SpA。27%的泛葡萄膜炎转诊患者和33.3%首次临床发现后节受累的患者被检测出患有BD。三分之二的后葡萄膜炎患者被检测出患有双侧葡萄膜炎,且复发率较高(P=0.014):结论:在出现不同类型葡萄膜炎的患者中,约有三分之一被查出患有风湿病。对葡萄膜炎患者进行全身风湿病检查至关重要,因为这可能会改变诊断和治疗过程。
{"title":"Rheumatic diseases detected in patients presenting with uveitis.","authors":"Esin Ozturk, Tuba Yuce Inel, Mahmut Kaya, Gercek Sen","doi":"10.14744/nci.2023.14564","DOIUrl":"10.14744/nci.2023.14564","url":null,"abstract":"<p><strong>Objective: </strong>Uveitis may occur in the course of systemic inflammatory rheumatic diseases (IRD), or it may be the first clinical manifestation of these diseases. The aim of this study was to determine the incidence of IRD in patients whose initial clinical manifestation was non-infectious uveitis.</p><p><strong>Methods: </strong>The study included adult patients diagnosed as having noninfectious uveitis in the department of ophthalmology and referred to rheumatology for further investigation of potential rheumatic diseases as underlying etiology of uveitis. The patients' demographic and clinical features, laboratory, and imaging findings were examined.</p><p><strong>Results: </strong>One hundred six patients who were diagnosed as having uveitis (42.4% anterior, 2.8% intermediate, 19.8% posterior, and 34.9% panuveitis) were included. Just over half (52.8%) of the patients were male and the mean age was 40.1±14.8 years. The mean age at the uveitis attack was 38.7±15 years. One-third (33%) of the patients were diagnosed as having rheumatologic disease (spondyloarthritis (SpA) n=10, Behcet disease (BD) n=17, vasculitides n=2, sarcoidosis n=2, undifferentiated connective tissue diseases n=3, rheumatoid arthritis n=1). SpA was diagnosed in 20% of patients presenting with anterior uveitis. BD was detected in 27% of patients referred with panuveitis and in 33.3% of patients whose first clinical finding was posterior segment involvement. Bilateral uveitis was detected in two-thirds of patients with posterior uveitis and tended to recur more frequently (p=0.014).</p><p><strong>Conclusion: </strong>Rheumatic diseases have been identified in approximately one-third of patients presenting with different types of uveitis. Investigations addressing systemic rheumatic diseases are of paramount importance in patients with uveitis because they may change diagnosis and treatment processes.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"406-413"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142486180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of quantitative evaluation of constipation in children with lower urinary tract dysfunction. 对患有下尿路功能障碍的儿童进行便秘定量评估的重要性。
Pub Date : 2024-09-30 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.59827
Tarik Emre Sener, Dogancan Dorucu, Sebahat Cam

Objective: There is a known association between lower urinary tract dysfunction (LUTD) and constipation. The objective of this study was to investigate any correlation between voiding and bowel symptoms in children with LUTD.

Methods: Children presenting with LUTD to our pediatric urology unit were prospectively included. Demographic data were recorded. All patients filled out the "Pediatric Lower Urinary Tract Symptom Score" (P-LUTSS) and "Constipation and Fecal Incontinence Symptom Severity" (CFISS) questionnaires. Symptom score correlation and associations with clinical findings were evaluated.

Results: 76 patients were included. The mean P-LUTSS was 11±7.1; mean CFISS was 7.7±7.5. According to P-LUTSS risk groups, median CFISS score increased as the risk group was increased. There was direct correlation between P-LUTSS and CFISS for all patients. 6th, 7th, 8th, 9th, 10th and 13th questions of P-LUTSS were correlated with CFISS; the 1st and 7th questions of CFISS were correlated with P-LUTSS. Patients who responded not to have constipation on P-LUTSS had lower CFISS scores compared to those who had constipation. Patients who had a 0 score on CFISS had a mean P-LUTSS of 7.7±6.2, which put the majority of patients in low-risk group. Also, out of these 11 patients, 10 of them responded to have no constipation on P-LUTSS.

Conclusion: A relationship between LUTD and bowel symptoms, as well as the positive correlation between P-LUTSS and CFISS was demonstrated in this study. Patients presenting with LUTD should undergo meticulous evaluation using special questionnaires for bowel symptoms. Only by then, a complete treatment approach can be provided.

目的:众所周知,下尿路功能障碍(LUTD)与便秘之间存在关联。本研究旨在调查下尿路功能障碍患儿的排尿和排便症状之间是否存在关联:方法:前瞻性地纳入在本院儿科泌尿科就诊的 LUTD 患儿。记录人口统计学数据。所有患者都填写了 "小儿下尿路症状评分"(P-LUTSS)和 "便秘和大便失禁症状严重程度"(CFISS)问卷。评估了症状评分与临床结果的相关性和关联性:共纳入 76 名患者。平均 P-LUTSS 为 11±7.1;平均 CFISS 为 7.7±7.5。根据 P-LUTSS 风险组别,CFISS 中位数得分随着风险组别的增加而增加。所有患者的 P-LUTSS 和 CFISS 之间存在直接相关性。P-LUTSS的第6、7、8、9、10和13个问题与CFISS相关;CFISS的第1和7个问题与P-LUTSS相关。与有便秘的患者相比,对 P-LUTSS 回答无便秘的患者的 CFISS 分数较低。CFISS 得分为 0 的患者的 P-LUTSS 平均值为 7.7±6.2,因此大多数患者属于低风险组。此外,在这 11 名患者中,有 10 人在 P-LUTSS 评分中没有便秘症状:本研究证实了 LUTD 与肠道症状之间的关系,以及 P-LUTSS 与 CFISS 之间的正相关性。LUTD 患者应使用专门的肠道症状问卷进行细致评估。只有这样,才能提供完整的治疗方法。
{"title":"The importance of quantitative evaluation of constipation in children with lower urinary tract dysfunction.","authors":"Tarik Emre Sener, Dogancan Dorucu, Sebahat Cam","doi":"10.14744/nci.2023.59827","DOIUrl":"10.14744/nci.2023.59827","url":null,"abstract":"<p><strong>Objective: </strong>There is a known association between lower urinary tract dysfunction (LUTD) and constipation. The objective of this study was to investigate any correlation between voiding and bowel symptoms in children with LUTD.</p><p><strong>Methods: </strong>Children presenting with LUTD to our pediatric urology unit were prospectively included. Demographic data were recorded. All patients filled out the \"Pediatric Lower Urinary Tract Symptom Score\" (P-LUTSS) and \"Constipation and Fecal Incontinence Symptom Severity\" (CFISS) questionnaires. Symptom score correlation and associations with clinical findings were evaluated.</p><p><strong>Results: </strong>76 patients were included. The mean P-LUTSS was 11±7.1; mean CFISS was 7.7±7.5. According to P-LUTSS risk groups, median CFISS score increased as the risk group was increased. There was direct correlation between P-LUTSS and CFISS for all patients. 6<sup>th</sup>, 7<sup>th</sup>, 8<sup>th</sup>, 9<sup>th</sup>, 10<sup>th</sup> and 13<sup>th</sup> questions of P-LUTSS were correlated with CFISS; the 1<sup>st</sup> and 7<sup>th</sup> questions of CFISS were correlated with P-LUTSS. Patients who responded not to have constipation on P-LUTSS had lower CFISS scores compared to those who had constipation. Patients who had a 0 score on CFISS had a mean P-LUTSS of 7.7±6.2, which put the majority of patients in low-risk group. Also, out of these 11 patients, 10 of them responded to have no constipation on P-LUTSS.</p><p><strong>Conclusion: </strong>A relationship between LUTD and bowel symptoms, as well as the positive correlation between P-LUTSS and CFISS was demonstrated in this study. Patients presenting with LUTD should undergo meticulous evaluation using special questionnaires for bowel symptoms. Only by then, a complete treatment approach can be provided.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"373-381"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of post-treatment radiological findings with relapses in idiopathic granulomatous mastitis patients. 特发性肉芽肿性乳腺炎患者治疗后放射学检查结果与复发的关系
Pub Date : 2024-09-30 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.32309
Gunay Rona, Meral Arifoglu, Kenan Cetin, Muhammet Fikri Kundes

Objective: The aim of this study is to investigate the relationship between post-treatment radiological findings and recurrences in idiopathic granulomatous mastitis (IGM).

Methods: Clinical data, ultrasound (US) and magnetic resonance imaging (MRI) examinations of 160 patients with IGM (mean age 34.6±7 years; range 20-56 years) who received only steroid or steroid+surgical treatment were evaluated retrospectively. Patients were grouped as radiological complete response (RCR) or radiological incomplete response (RIR).

Results: Only in the steroid group, 79 (54.1%) patients were in the RCR group and 67 (45.9%) patients were in the RIR group. Recurrence occurred in 42 (26.3%) patients, 27 (16.9%) in the same breast and 15 (9.4%) in the contralateral breast. Most of the recurrences in the same breast had residual lesions up to recurrence (74.1%).

Conclusion: Residual lesion after treatment is a risk factor for recurrence, and treatment can significantly reduce recurrences until the lesions disappear. The lesion size on MRI after treatment is not associated with recurrence.

目的本研究旨在探讨特发性肉芽肿性乳腺炎(IGM)治疗后放射学检查结果与复发之间的关系:回顾性评估了160例只接受类固醇治疗或类固醇+手术治疗的特发性肉芽肿性乳腺炎患者(平均年龄34.6±7岁;范围20-56岁)的临床数据、超声波(US)和磁共振成像(MRI)检查结果。患者被分为放射学完全反应组(RCR)和放射学不完全反应组(RIR):仅在类固醇治疗组中,就有 79 例(54.1%)患者属于 RCR 组,67 例(45.9%)患者属于 RIR 组。42例(26.3%)患者复发,其中27例(16.9%)发生在同侧乳房,15例(9.4%)发生在对侧乳房。在同侧乳房复发的患者中,大多数在复发前有残留病灶(74.1%):结论:治疗后的残留病灶是复发的危险因素,治疗可显著减少复发,直至病灶消失。治疗后磁共振成像显示的病灶大小与复发无关。
{"title":"Relationship of post-treatment radiological findings with relapses in idiopathic granulomatous mastitis patients.","authors":"Gunay Rona, Meral Arifoglu, Kenan Cetin, Muhammet Fikri Kundes","doi":"10.14744/nci.2023.32309","DOIUrl":"10.14744/nci.2023.32309","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to investigate the relationship between post-treatment radiological findings and recurrences in idiopathic granulomatous mastitis (IGM).</p><p><strong>Methods: </strong>Clinical data, ultrasound (US) and magnetic resonance imaging (MRI) examinations of 160 patients with IGM (mean age 34.6±7 years; range 20-56 years) who received only steroid or steroid+surgical treatment were evaluated retrospectively. Patients were grouped as radiological complete response (RCR) or radiological incomplete response (RIR).</p><p><strong>Results: </strong>Only in the steroid group, 79 (54.1%) patients were in the RCR group and 67 (45.9%) patients were in the RIR group. Recurrence occurred in 42 (26.3%) patients, 27 (16.9%) in the same breast and 15 (9.4%) in the contralateral breast. Most of the recurrences in the same breast had residual lesions up to recurrence (74.1%).</p><p><strong>Conclusion: </strong>Residual lesion after treatment is a risk factor for recurrence, and treatment can significantly reduce recurrences until the lesions disappear. The lesion size on MRI after treatment is not associated with recurrence.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"391-397"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors and outcomes related to new-onset acute kidney injury in septic medical intensive care unit patients. 脓毒症内科重症监护室患者新发急性肾损伤的相关因素和结果。
Pub Date : 2024-09-27 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.30040
Kamil Inci, Gulbin Aygencel, Nazlihan Boyaci Dundar, Ozant Helvaci, Melda Turkoglu

Objective: Sepsis-induced acute kidney injury (AKI) is a significant threat, contributing to worse outcomes in intensive care unit (ICU) patients. Thus, understanding the complex relationship between sepsis and renal dysfunction in ICU patients is crucial. We aimed to investigate the factors that may predispose to the development and the clinical consequences of new-onset AKI in septic medical ICU patients in this study.

Methods: This retrospective cohort was conducted between December 2019 and April 2023 in the tertiary medical ICU of Gazi University Hospital, Ankara, Turkiye. Participants included septic medical ICU patients aged ≥18 without AKI on ICU admission. Data included demographics, comorbidities, disease severity and prognostic scoring, ICU admission, and ICU follow-up data. Statistical analyses, including logistic regression, were performed to identify independent risk factors for new-onset AKI development and ICU mortality.

Results: Patients with new-onset AKI (36% incidence) had higher APACHE-II (21 [16-27] vs. 16 [12-18]) and SOFA (6 [3-9] vs. 3 [2-5]) scores and lower GCS (10 [6-15] vs. 14 [10-15]) on ICU admission (p<0.01 for all results). Independent risk factors for both new AKI development and ICU mortality included invasive mechanical ventilation (IMV) (OR (95% CI): 5.02 [1.59-15] for AKI and OR (95% CI): 13.2 [3-58.8] for ICU mortality, p<0.01), new-onset shock (OR (95% CI): 3.98 [1.42-11.1] for AKI, OR (95% CI): 14.5 [4.4-43.5] for mortality, p<0.01), and higher APACHE-II score (OR (95% CI): 1.08 [1.01-1.16]), for AKI, p=0.05 and (OR (95% CI): 1.04 [1.01-1.08], for mortality, p=0.01). AKI was more frequent in patients whose source of infection was the respiratory system (45% vs. 29%, p=0.01) and catheter-related bloodstream infection (CRBSI) (17% vs. 8%, p=0.03) than those who did not. New AKI development was associated with longer ICU stay (9 [5-18] vs. 5 [3-10] days, p<0.01) and was independently associated with ICU mortality (OR (95% CI): 28.6 [6.6-125], p<0.01).

Conclusion: This study reveals new-onset AKI incidence of 36% in septic medical ICU patients. Additionally, it underlines the potential impact of infection sources on new AKI development. New-onset shock, IMV, and disease severity were independently associated with both new-onset AKI and ICU mortality in this population.

目的:脓毒症诱发的急性肾损伤(AKI)是一个重大威胁,会导致重症监护病房(ICU)患者的预后恶化。因此,了解脓毒症与 ICU 患者肾功能障碍之间的复杂关系至关重要。本研究旨在探讨脓毒症内科重症监护病房患者新发 AKI 的诱发因素和临床后果:这项回顾性队列研究于 2019 年 12 月至 2023 年 4 月期间在土耳其安卡拉加齐大学医院的三级内科 ICU 进行。参与者包括年龄≥18 岁、入院时无 AKI 的脓毒症内科 ICU 患者。数据包括人口统计学、合并症、疾病严重程度和预后评分、ICU入院和ICU随访数据。研究人员进行了包括逻辑回归在内的统计分析,以确定新发 AKI 发生和 ICU 死亡率的独立风险因素:结果:新发 AKI 患者(发生率为 36%)入 ICU 时的 APACHE-II 评分(21 [16-27] vs. 16 [12-18])和 SOFA 评分(6 [3-9] vs. 3 [2-5])较高,GCS 评分(10 [6-15] vs. 14 [10-15])较低(p 结论:该研究揭示了新发 AKI 的风险因素:本研究显示,脓毒症内科 ICU 患者新发 AKI 的发生率为 36%。此外,研究还强调了感染源对新发 AKI 的潜在影响。在这一人群中,新发休克、IMV和疾病严重程度与新发AKI和ICU死亡率均有独立关联。
{"title":"Factors and outcomes related to new-onset acute kidney injury in septic medical intensive care unit patients.","authors":"Kamil Inci, Gulbin Aygencel, Nazlihan Boyaci Dundar, Ozant Helvaci, Melda Turkoglu","doi":"10.14744/nci.2024.30040","DOIUrl":"10.14744/nci.2024.30040","url":null,"abstract":"<p><strong>Objective: </strong>Sepsis-induced acute kidney injury (AKI) is a significant threat, contributing to worse outcomes in intensive care unit (ICU) patients. Thus, understanding the complex relationship between sepsis and renal dysfunction in ICU patients is crucial. We aimed to investigate the factors that may predispose to the development and the clinical consequences of new-onset AKI in septic medical ICU patients in this study.</p><p><strong>Methods: </strong>This retrospective cohort was conducted between December 2019 and April 2023 in the tertiary medical ICU of Gazi University Hospital, Ankara, Turkiye. Participants included septic medical ICU patients aged ≥18 without AKI on ICU admission. Data included demographics, comorbidities, disease severity and prognostic scoring, ICU admission, and ICU follow-up data. Statistical analyses, including logistic regression, were performed to identify independent risk factors for new-onset AKI development and ICU mortality.</p><p><strong>Results: </strong>Patients with new-onset AKI (36% incidence) had higher APACHE-II (21 [16-27] vs. 16 [12-18]) and SOFA (6 [3-9] vs. 3 [2-5]) scores and lower GCS (10 [6-15] vs. 14 [10-15]) on ICU admission (p<0.01 for all results). Independent risk factors for both new AKI development and ICU mortality included invasive mechanical ventilation (IMV) (OR (95% CI): 5.02 [1.59-15] for AKI and OR (95% CI): 13.2 [3-58.8] for ICU mortality, p<0.01), new-onset shock (OR (95% CI): 3.98 [1.42-11.1] for AKI, OR (95% CI): 14.5 [4.4-43.5] for mortality, p<0.01), and higher APACHE-II score (OR (95% CI): 1.08 [1.01-1.16]), for AKI, p=0.05 and (OR (95% CI): 1.04 [1.01-1.08], for mortality, p=0.01). AKI was more frequent in patients whose source of infection was the respiratory system (45% vs. 29%, p=0.01) and catheter-related bloodstream infection (CRBSI) (17% vs. 8%, p=0.03) than those who did not. New AKI development was associated with longer ICU stay (9 [5-18] vs. 5 [3-10] days, p<0.01) and was independently associated with ICU mortality (OR (95% CI): 28.6 [6.6-125], p<0.01).</p><p><strong>Conclusion: </strong>This study reveals new-onset AKI incidence of 36% in septic medical ICU patients. Additionally, it underlines the potential impact of infection sources on new AKI development. New-onset shock, IMV, and disease severity were independently associated with both new-onset AKI and ICU mortality in this population.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"414-421"},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between the degree of visceral pleural invasion and survival in non-small cell lung cancer. 非小细胞肺癌内脏胸膜侵犯程度与存活率之间的关系。
Pub Date : 2024-09-12 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.25349
Seyma Ozden, Isil Gokdemir, Murat Kiyik

Objective: The aim of this study was to evaluate the relationship between the degree of visceral pleural invasion (VPI) and survival in patients operated for non-small cell lung cancer (NSCLC).

Methods: Between 2013 and 2015, 202 patients who were diagnosed with NSCLC in our center and followed up in our clinic were retrospectively evaluated. To examine the preoperative and postoperative prognostic factors of the patients, postoperative pathology results, demographic data and data on recurrence status were obtained from our hospital database and patient files.

Results: VPI Survival analysis was performed by dividing 3 groups: PL0, PL1 and PL2. Mean survival (MS) was calculated as 39.528±1.469 (36.655-42.402; 95% CI) months for PL0, 35.136±3.115 (29.031-41.240; 95% CI) months for PL1, and 24.688±3.697 (17.441-31.934; 95% CI) for PL2 (p=0.020). When we consider PL0 and PL1 as a single group and compare it with PL2, the MS time of the PL0-PL1 group was 38.358±1.346 (35.721-40.995; 95% CI) months, while the MS time of the PL2 group was 24.688±3.697 (17.441-31.934; 95% CI) months (p=0.020).

Conclusion: Although PL0, PL1 and PL2 were classified into a single group (all considered as T2), this study showed that the presence of PL2 was associated with a poor prognosis in terms of survival, independent of lymph node involvement, histopathological subtype of the tumor and tumor size.

研究目的本研究旨在评估非小细胞肺癌(NSCLC)手术患者内脏胸膜侵犯(VPI)程度与生存期之间的关系:方法:回顾性评估2013年至2015年间在本中心确诊并在本诊所随访的202例非小细胞肺癌患者。为了研究患者的术前和术后预后因素,我们从医院数据库和患者档案中获取了术后病理结果、人口统计学数据和复发状况数据:VPI 生存分析分为三组:PL0、PL1 和 PL2:PL0、PL1 和 PL2。PL0的平均生存期(MS)为39.528±1.469(36.655-42.402;95% CI)个月,PL1为35.136±3.115(29.031-41.240;95% CI)个月,PL2为24.688±3.697(17.441-31.934;95% CI)个月(P=0.020)。当我们将 PL0 和 PL1 视为一组并与 PL2 进行比较时,PL0-PL1 组的 MS 时间为(38.358±1.346)个月(35.721-40.995;95% CI),而 PL2 组的 MS 时间为(24.688±3.697)个月(17.441-31.934;95% CI)(P=0.020):虽然PL0、PL1和PL2被归为一组(均被视为T2),但本研究表明,PL2的存在与预后不良的生存率有关,与淋巴结受累、肿瘤组织病理学亚型和肿瘤大小无关。
{"title":"The relationship between the degree of visceral pleural invasion and survival in non-small cell lung cancer.","authors":"Seyma Ozden, Isil Gokdemir, Murat Kiyik","doi":"10.14744/nci.2023.25349","DOIUrl":"10.14744/nci.2023.25349","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to evaluate the relationship between the degree of visceral pleural invasion (VPI) and survival in patients operated for non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>Between 2013 and 2015, 202 patients who were diagnosed with NSCLC in our center and followed up in our clinic were retrospectively evaluated. To examine the preoperative and postoperative prognostic factors of the patients, postoperative pathology results, demographic data and data on recurrence status were obtained from our hospital database and patient files.</p><p><strong>Results: </strong>VPI Survival analysis was performed by dividing 3 groups: PL0, PL1 and PL2. Mean survival (MS) was calculated as 39.528±1.469 (36.655-42.402; 95% CI) months for PL0, 35.136±3.115 (29.031-41.240; 95% CI) months for PL1, and 24.688±3.697 (17.441-31.934; 95% CI) for PL2 (p=0.020). When we consider PL0 and PL1 as a single group and compare it with PL2, the MS time of the PL0-PL1 group was 38.358±1.346 (35.721-40.995; 95% CI) months, while the MS time of the PL2 group was 24.688±3.697 (17.441-31.934; 95% CI) months (p=0.020).</p><p><strong>Conclusion: </strong>Although PL0, PL1 and PL2 were classified into a single group (all considered as T2), this study showed that the presence of PL2 was associated with a poor prognosis in terms of survival, independent of lymph node involvement, histopathological subtype of the tumor and tumor size.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"367-372"},"PeriodicalIF":0.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxygen titration with Oxygen Reserve Index in minimally invasive repair of pectus excavatum, a randomized controlled trial. 用氧储备指数滴定微创修复乳房下垂,随机对照试验。
Pub Date : 2024-09-11 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.45556
Agshin Mirzayev, Gul Cakmak, Ruslan Abdullayev, Tunc Lacin, Zuhal Aykac, Ayten Saracoglu

Objective: Perioperative hypoxemia is common during minimally invasive repair of pectus excavatum (MIRPE). Oxygen Reserve Index (ORI™) is a noninvasive method that shows blood oxygenation status. In addition, this method provides information about hypoxemia earlier than pulse oximetry. The primary aim of this study was to examine the value of ORI monitoring as an early predictor of hypoxemia during surgery. The secondary aim was to evaluate the value of ORI monitoring as a guide for oxygen titration to prevent hyperoxemia.

Methods: This randomized controlled study enrolled 128 pediatric patients aged 8-18 years scheduled for elective MIRPE surgery. Patients were followed up with continuous peripheral oxygen saturation (SpO2) measurement in the control group (Group C) and continuous ORI monitoring in the study group (Group O). After pneumothorax, a decrease of 1% in basal SpO2 and 0.05 from basal ORI was considered clinically significant. Patient demographics, pre-induction, pre-first and second pneumothorax, and postoperative ORI, mean arterial pressure, temperature, perfusion index, end-tidal carbon dioxide values, length of hospital stay, anesthesia, and surgery durations were recorded.

Results: Desaturation time was 59.46±15.57 seconds in Group O based on ORI, and 177.64±20.94 seconds in Group C according to SpO2, and the difference was significant (p<0.001). Use of FiO2>0.6 was lower in Group O, compared with Group C (p<0.05). Length of hospital stay was lower in Group O (p=0.002).

Conclusion: ORI may detect hypoxemia earlier than SpO2 monitoring during MIRPE surgery. ORI monitorization decreases exposure time to high oxygen concentrations and may increase patient safety during MIRPE surgery in pediatric patients.

目的:微创修复开胸手术(MIRPE)围手术期常见低氧血症。氧储备指数 (ORI™) 是一种无创方法,可显示血氧状态。此外,这种方法比脉搏血氧仪更早提供低氧血症的信息。本研究的主要目的是研究 ORI 监测作为手术期间低氧血症早期预测指标的价值。次要目的是评估 ORI 监测作为氧气滴定指南以防止高氧血症的价值:这项随机对照研究招募了 128 名年龄在 8-18 岁、计划接受 MIRPE 手术的儿科患者。对照组(C 组)患者接受连续外周血氧饱和度(SpO2)测量,研究组(O 组)患者接受连续 ORI 监测。气胸发生后,基础 SpO2 下降 1%、基础 ORI 下降 0.05 即被视为有临床意义。研究记录了患者的人口统计学特征、诱发前、第一次和第二次气胸前、术后 ORI、平均动脉压、体温、灌注指数、潮气末二氧化碳值、住院时间、麻醉和手术持续时间:结果:根据 ORI,O 组的血氧饱和时间为(59.46±15.57)秒,而根据 SpO2,C 组的血氧饱和时间为(177.64±20.94)秒,与 C 组相比,O 组的血氧饱和时间更短,差异显著(p2>0.6):在 MIRPE 手术中,ORI 可比 SpO2 监测更早发现低氧血症。ORI 监测减少了暴露于高浓度氧气的时间,可提高儿科患者在 MIRPE 手术中的安全性。
{"title":"Oxygen titration with Oxygen Reserve Index in minimally invasive repair of pectus excavatum, a randomized controlled trial.","authors":"Agshin Mirzayev, Gul Cakmak, Ruslan Abdullayev, Tunc Lacin, Zuhal Aykac, Ayten Saracoglu","doi":"10.14744/nci.2023.45556","DOIUrl":"10.14744/nci.2023.45556","url":null,"abstract":"<p><strong>Objective: </strong>Perioperative hypoxemia is common during minimally invasive repair of pectus excavatum (MIRPE). Oxygen Reserve Index (ORI™) is a noninvasive method that shows blood oxygenation status. In addition, this method provides information about hypoxemia earlier than pulse oximetry. The primary aim of this study was to examine the value of ORI monitoring as an early predictor of hypoxemia during surgery. The secondary aim was to evaluate the value of ORI monitoring as a guide for oxygen titration to prevent hyperoxemia.</p><p><strong>Methods: </strong>This randomized controlled study enrolled 128 pediatric patients aged 8-18 years scheduled for elective MIRPE surgery. Patients were followed up with continuous peripheral oxygen saturation (SpO<sub>2</sub>) measurement in the control group (Group C) and continuous ORI monitoring in the study group (Group O). After pneumothorax, a decrease of 1% in basal SpO<sub>2</sub> and 0.05 from basal ORI was considered clinically significant. Patient demographics, pre-induction, pre-first and second pneumothorax, and postoperative ORI, mean arterial pressure, temperature, perfusion index, end-tidal carbon dioxide values, length of hospital stay, anesthesia, and surgery durations were recorded.</p><p><strong>Results: </strong>Desaturation time was 59.46±15.57 seconds in Group O based on ORI, and 177.64±20.94 seconds in Group C according to SpO<sub>2</sub>, and the difference was significant (p<0.001). Use of FiO<sub>2</sub>>0.6 was lower in Group O, compared with Group C (p<0.05). Length of hospital stay was lower in Group O (p=0.002).</p><p><strong>Conclusion: </strong>ORI may detect hypoxemia earlier than SpO<sub>2</sub> monitoring during MIRPE surgery. ORI monitorization decreases exposure time to high oxygen concentrations and may increase patient safety during MIRPE surgery in pediatric patients.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"382-390"},"PeriodicalIF":0.0,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conducting risk assessments and case detection in online environments in the scope of fight with COVID-19. 在打击 COVID-19 的范围内,对在线环境进行风险评估和案件侦查。
Pub Date : 2024-09-10 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.56659
Banu Cakir
{"title":"Conducting risk assessments and case detection in online environments in the scope of fight with COVID-19.","authors":"Banu Cakir","doi":"10.14744/nci.2023.56659","DOIUrl":"10.14744/nci.2023.56659","url":null,"abstract":"","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 5","pages":"492-493"},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Northern clinics of Istanbul
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1